These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26926640)

  • 1. Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?
    Bidell MR; Palchak M; Mohr J; Lodise TP
    Antimicrob Agents Chemother; 2016 May; 60(5):3170-3. PubMed ID: 26926640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Caron F; Etienne M
    Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU).
    Choe HS; Lee SJ; Cho YH; Çek M; Tandoğdu Z; Wagenlehner F; Bjerklund-Johansen TE; Naber K;
    J Infect Chemother; 2018 Apr; 24(4):278-283. PubMed ID: 29292177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study.
    Rosé L; Coulter MM; Chan S; Hossain J; Di Pentima MC
    J Med Microbiol; 2015 Jul; 64(7):778-781. PubMed ID: 26231748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007.
    Wada K; Kariyama R; Mitsuhata R; Uehara S; Watanabe T; Monden K; Kumon H
    Acta Med Okayama; 2009 Oct; 63(5):263-72. PubMed ID: 19893602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):25. PubMed ID: 28390438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
    Hefzy EM; Hassuna NA
    Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
    Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistant phenotypes of Escherichia coli strains responsible for urinary tract infection in the laboratory of the University Hospital Joseph Raseta Befelatanana, Antananarivo].
    Rakotovao-Ravahatra ZD; Randriatsarafara FM; Rasoanandrasana S; Raverohanta L; Rakotovao AL
    Pan Afr Med J; 2017; 26():166. PubMed ID: 28674559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.
    Boyd LB; Atmar RL; Randall GL; Hamill RJ; Steffen D; Zechiedrich L
    BMC Infect Dis; 2008 Jan; 8():4. PubMed ID: 18197977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
    Low M; Neuberger A; Hooton TM; Green MS; Raz R; Balicer RD; Almog R
    Lancet Infect Dis; 2019 Apr; 19(4):419-428. PubMed ID: 30846277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.
    Cohen AE; Lautenbach E; Morales KH; Linkin DR
    Am J Med; 2006 Nov; 119(11):958-63. PubMed ID: 17071164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug susceptibility and treatment response of common urinary tract infection pathogens in children.
    Chen PC; Chang LY; Lu CY; Shao PL; Tsai IJ; Tsau YK; Lee PI; Chen JM; Hsueh PR; Huang LM
    J Microbiol Immunol Infect; 2014 Dec; 47(6):478-83. PubMed ID: 24064294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.
    Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E
    Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.